Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • AbstractLocoregional recurrences represent a frequently unexpected problem in head and neck squamous cell carcinoma (HNSCC). Relapse often (10–30%) occurs in patients with histologically negative resection margins (RMs), probably due to residual tumor cells or hidden pre-cancerous lesions in normal mucosa, both missed by histopathological examination. Therefore, definition of a ‘clean’ or tumor-negative RM is controversial, demanding for novel approaches to be accurately explored. Here, we evaluated next generation sequencing (NGS) and digital PCR (dPCR) as tools to profile TP53 mutational status and circulating microRNA expression aiming at scoring the locoregional risk of recurrence by means of molecular analyses. Serial monitoring of these biomarkers allowed identifying patients at high risk, laying the ground for accurate tracking of disease evolution and potential intensification of post-operative treatments. Additionally, our pipeline demonstrated its applicability into the clinical routine, being cost-effective and feasible in terms of patient sampling, holding promise to accurately (re)-stage RMs in the era of precision medicine.

authors

  • Ganci, Federica
  • Allegretti, Matteo
  • Frascolla, Carlotta
  • Spinella, Francesca
  • Rollo, Francesca
  • Sacconi, Andrea
  • Valentina, Pascale De
  • Palcau, Alina Catalina
  • Manciocco, Valentina
  • Vescovo, Mariavittoria
  • Cotroneo, Ettore
  • Blandino, Francesca
  • Benevolo, Maria
  • Covello, Renato
  • Muti, Paola
  • Strano, Sabrina
  • Vidiri, Antonello
  • Fontemaggi, Giulia
  • Pellini, Raul
  • Blandino, Giovanni

publication date

  • March 5, 2024